Realising the ROI of investing in clinical research

Consumers are demanding efficacious nutraceutical products, and are increasingly asking for the science behind them. Clinical trials on ingredients and formulas are critical to communicate directly and with confidence. Understanding how to choose the right clinical research partner, develop protocols, and message appropriately are all considerations to be addressed. Get insights around critical considerations including:

• Why is more clinical research into individual nutraceutical ingredients and compounds necessary?
• What is the value to investing in clinical research on natural compounds?
• How can you ensure that you have the IP protection for your ingredients and that the research will strengthen that position?
• How do you ensure the protocol is developed to give useful outcomes, and that it is appropriately powered?

This panel discussion brings together thought leaders to share their take on important considerations around undertaking clinical research on nutritional ingredients, and maximising the return on investment.

Speakers

	Dr Andreas Biller Principal, Dr Biller Biosulting & Pharma   Dr Andreas Biller is the founder of Dr Biller Biosulting & Pharma. He worked previously as the managing director of medium-sized pharmaceutical companies, overseeing growth and development. He has growth-oriented management experience in business development, production, medicine and corporate development. He has developed innovative, scientifically proven medicinal products and food supplements, and has proven success in founding and expanding new business areas and customer groups
	Jennifer Murphy, MS, RD Director of Innovation & Clinical Development, PLT Health Solutions   Jen Murphy is a registered dietitian with a master’s in clinical nutrition from the University of Pittsburgh. In her role with PLT Health Solutions, she leverages more than a decade of experience with expertise in ingredient development and a strong foundation in clinical design for claims substantiation.  Jen has helped to guide innovation and commercialization strategies for hundreds of products. Prior to joining PLT, Jen was R&D manager in technology and product innovation at GNC, where she worked on new product ideation, product formulation, and scientific review of ingredient studies for claims development. The latter involved working closely with ingredient partners to improve clinical designs and optimize their ability to substantiate claims. While at GNC, Jen also led their ingredient discovery program, which focused on identifying best in class, clinically supported ingredients to drive new product innovation.
	Juan Arias Founding & Managing Partner, ABG Intellectual Property   Juan Arias co-founded ABG Intellectual Property in 2003. He has more than 30 years of patent experience. His practice focuses on patent prosecution, including EPO oppositions, opinion work, including freedom to operate and validity opinions, and litigation support in the areas of organic chemistry and pharmaceuticals. Additionally, he has participated as a technical expert in numerous cases of patent litigation in Spain. He is a qualified European Patent Attorney (EQE, 2004) and a Spanish Patent and Trademark Agent (2003). Before founding ABG, Juan headed the Chemistry Department at a Spanish IP firm in Madrid (2000 to 2003) and was an examiner at the European Patent Office in Munich (1991-2000). Prior to his patent career, Juan performed research on protein chemistry at the Max-Planck-Institut für Biochemie in Munich (1989-90).

Vitafoods Insights Clinical Trials Digital Day was brought to you by: